ResearchAndMarkets.com releases "Digital Therapeutics: A New Age Medicine"
ResearchAndMarkets.com’s "Digital Therapeutics: A New Age Medicine" report expects the digital therapeutics (DTx) global market to reach $13.9 billion by 2027, at a 28.1% CAGR. DTx is considered a subset of digital health and factors for its growth include tools that allow for better involvement of the patient in the management of the disease, specifically in chronic diseases; increased investment this space; growing research activities, and the increasing use of smartphones, mhealth apps, and wearables.
Read more about the DTx market.
FDA issues de novo clearance for SonoMotion’s Stone Clear device, for kidney stone treatment
Stone Clear is the first and only device cleared by the FDA that uses external ultrasound pulses to facilitate passage of post-lithotripsy kidney stone fragments without surgery.